Status:
UNKNOWN
PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Frailty
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter, observational, retrospective and prospective study for the evaluation of precision medicine to target frailty of endocrine-metabolic origin, with a genetic study.
Detailed Description
Overall summary Frailty results from the lifelong accumulation of damage caused by age- and disease-related impairment of the repair network. The amount of cellular damage needed to alter function is ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- presence of endocrine and metabolic diseases (hypothalamic-pituitary-gonadal and adrenal diseases, type 2 diabetes mellitus, and bone diseases);
- signed informed consent to participate in the study.
Exclusion
Key Trial Info
Start Date :
August 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 9 2024
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT04856683
Start Date
August 10 2020
End Date
August 9 2024
Last Update
November 23 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy, 50134
2
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy, 20122
3
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Rome, Italy, 00161
4
Ospedale San Giovanni Calibita-Fatebenefratelli Fondazione Fatebenefratelli per la Ricerca e la Formazione Sanitaria e Sociale
Rome, Italy, 00186